Welcome to our dedicated page for trmnd news (Ticker: trmnd), a resource for investors and traders seeking the latest updates and insights on trmnd stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect trmnd's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of trmnd's position in the market.
New Wave Holdings Corp. (OTC: TRMND) announced its sponsorship of the upcoming documentary "The World on Drugs," addressing drug policy, psychedelic medicine, and mental health issues. The film aims to reshape public perception regarding psychedelics amid the pandemic and mental health crises. Following initial filming in Mexico, the next phase will focus on Vancouver, featuring insights from mental health experts. New Wave is committed to supporting research and creating solutions in the psychedelic sector, highlighting its corporate social responsibility during challenging times.
New Wave Holdings Corp. (OTC: TRMND) announced its sponsorship of the documentary "The World on Drugs," focusing on drug policy, psychedelic medicine, and mental health. During a critical time marked by the pandemic and the opioid crisis, the project aims to reframe public perceptions of psychedelics. With funding for the next phase in Vancouver, the documentary will feature expert commentary and stories of individuals whose lives have improved through psychedelics. New Wave is committed to supporting advancements in mental healthcare through this initiative.
New Wave Holdings Corp. (OTC: TRMND) announced the launch of a new e-commerce site, Newbotanic.com, in collaboration with N2 Logics. The site will offer a variety of health and wellness products, including topical balms and facial cleansers, focusing on natural ingredients such as mushrooms and plant extracts. New Wave has signed a Letter of Intent (LOI) to acquire a 50% stake in N2 Logics, which will manage the development of the website. This initiative aligns with New Wave's investment focus on the psychedelic and esports sectors.
New Wave Holdings Corp. (OTC: TRMND) announced a joint venture with Joshua Neilly and Branislav Nikolic to form N2 Logics, a digital marketing company based in Ireland. New Wave will acquire a 50% stake in N2 Logics by purchasing 10,000,000 shares for CDN $150,000. N2 Logics specializes in enhancing e-commerce platforms, leveraging over 10 years of digital marketing experience. The collaboration aims to bolster online sales and marketing for New Wave's products, including CBD and functional mushrooms, expanding its global reach.
New Wave Holdings Corp. (OTC: TRMND) has appointed Daniel Fox as its new Chief Executive Officer, replacing Clayton Fisher, who has resigned. Daniel Fox is known for his extensive experience across various sectors, including alcoholic beverages and cannabis. In addition, Diego Gianelli has joined the Board of Directors, bringing over 20 years of experience in consumer brands and business transformations. This leadership change aims to enhance the company's focus on functional mushroom products and strengthen its position in the psychedelic sector.
FAQ
What is the market cap of trmnd (trmnd)?
